\xe2\x80\xa2 Draft quality assurance policies and procedures \xe2\x80\xa2 Interpret and implement quality assurance standards and procedures \xe2\x80\xa2 Evaluate adequacy of quality assurance standards \xe2\x80\xa2 Devise sampling procedures and directions for recording and reporting quality data \xe2\x80\xa2 Review the implementation and efficiency of quality and inspection systems \xe2\x80\xa2 Plan, conduct and monitor testing and inspection of materials and products to ensure finished product quality \xe2\x80\xa2 Document internal audits and other quality assurance activities \xe2\x80\xa2 Investigate customer complaints and non-conformance issues \xe2\x80\xa2 Collect and compile statistical quality data \xe2\x80\xa2 Analyze data to identify areas for improvement in the quality system \xe2\x80\xa2 Develop, recommend and monitor corrective and preventive actions \xe2\x80\xa2 Prepare reports to communicate outcomes of quality activities \xe2\x80\xa2 Identify training needs and organize training interventions to meet quality standards \xe2\x80\xa2 Coordinate and support on-site audits conducted by external providers \xe2\x80\xa2 Evaluate audit findings and implement appropriate corrective actions \xe2\x80\xa2 Monitor risk management activities \xe2\x80\xa2 Responsible for document management systems \xe2\x80\xa2 Assure ongoing compliance with quality and industry regulatory requirements \xe2\x80\xa2 To attend ad-hoc request Requirements \xe2\x80\xa2 Candidate must possess in Bachelor\xe2\x80\x99s Degree in Bioscience in chemistry or equivalent \xe2\x80\xa2 Good communication skills and interpersonal skills \xe2\x80\xa2 Willing to work beyond office hours when needs arise \xe2\x80\xa2 Able to start work immediately is an advantage
SGB has incorporated a new wholly-owned subsidiary, Solution Biologics Sdn. Bhd., to undertake the supply of vaccines and biologics. For the initial phase of the business, Solution Biologics Sdn. Bhd will operates a fill and finish facility dedicated to vaccines and biologics. The facility will be housed in the current manufacturing building at Technology Park Malaysia and expected to be operational by first quarter of 2021. Biologics and vaccines represent one of the fastest growing classes of therapeutic molecules in modern healthcare. The annual global biologics market is expected to be approximately USD 380 billion by 2024, representing a relatively higher growth rate (~8%) compared to conventional pharmaceuticals. Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Since biologics are quite large in comparison to chemical-based drugs and made up of proteins, they require extra care to maintain their size, shape, form, and stability. These factors correlate to the intended effect and efficiency of the biologic drug. We are committed to developing newer and more effective vaccines and biologics through research and development programme with our partners. Our plan for the future will include paediatric and adult vaccines that are part of the National Immunisation Schedule of Malaysia and the Extended Programme of Immunisation (EPI) of various countries in the region.
Bachelor\'s or Equivalent